Fingerprint
Dive into the research topics where Yongying Jiang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Structure-Guided Development of NRAS G12D Inhibitors Based on a 5-Azaindole Core
Cox, J. B., Nair, V., Mandal, P., Reyna, N., Tran, T., Mustachio, L. M., Bardenhagen, J., Fawver, J., Shepard, H., Hickey, A. M., Wu, Q., Rodriguez, C., Yu, F., Phan, P., Mendiola, A. J., Johnson, R., Thapar, R., Johnson, T., Jiang, Y. & Cross, J. B. & 6 others, , Feb 12 2026, In: ACS Medicinal Chemistry Letters. 17, 2, p. 425-432 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Allosteric targeting of RIPK1: discovery of novel inhibitors via parallel virtual screening and structure-guided optimization
Vijayan, R. S. K., Hamilton, M. M., Pfaffinger, D. E., Alvarez, F. G., Reyna, N. J., Bardenhagen, J. P., Shepard, H., Rodriguez, C., Goodwani, S., Lightfoot, Y., Maskos, K., Johannsson, S., Kempf, G., Xu, Q. A., Neumann, L., Jiang, Y., Do, M. G., Jones, P., Lewis, R. T. & Ray, W. J. & 1 others, , Nov 1 2025, In: MedChemComm. 16, 11, p. 5341-5358 18 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations -
A pilot study of lower doses of ibrutinib: patient body weight does not correlate with plasma ibrutinib levels during therapy
Chen, L. S., Bose, P., Qiao, W., Jiang, Y., Wu, Q., Cruz, N. D., Keating, M. J. & Gandhi, V., 2025, In: Leukemia and Lymphoma. 66, 6, p. 1166-1168 3 p.Research output: Contribution to journal › Letter › peer-review
-
Discovery of Novel, Potent, and Orally Bioavailable SMARCA2 Proteolysis-Targeting Chimeras with Synergistic Antitumor Activity in Combination with Kirsten Rat Sarcoma Viral Oncogene Homologue G12C Inhibitors
Kotagiri, S., Wang, Y., Han, Y., Liang, X., Blazanin, N., Mazhar, H., Sebastian, M., Nguyen, P. K., Jiang, Y. & Lissanu, Y., May 8 2025, In: Journal of Medicinal Chemistry. 68, 9, p. 9202-9219 18 p.Research output: Contribution to journal › Article › peer-review
Open Access9 Link opens in a new tab Scopus citations -
Nivolumab plus ipilimumab induce hyper-progression in renal medullary carcinoma: results of a phase II trial and preclinical evidence
Soeung, M., Yan, X., Zanca, C., Qian, J., Karki, M., Duan, F., Khan, H., Zhang, L., Peng, D. H., Williams, M., He, R., Chen, Z., Perelli, L., Chen, J., Tidwell, R. S., Chauhan, P. K., Le, C. N., Lam, T. N. A., Bhattacharya, N. & Shah, R. & 46 others, , Dec 2025, In: Nature communications. 16, 1, 10474.Research output: Contribution to journal › Article › peer-review
Open Access3 Link opens in a new tab Scopus citations